Monoammonium Glycyrrhizinate is the active compound derived from liquorice root. It is used in a wide variety of medical and cosmetic products, sweetener, as it produces excellent pharmacological effects such as anti-inflammatory, antiulcer and antiallergic actions.
Monoammonium glycyrrhizinate include food grade monoammonium glycyrrhizinate and medical grade monoammonium glycyrrhizinate, among them, food grade monoammonium glycyrrhizinate occupy the largest market share.
The monoammonium glycyrrhizinate market was valued at USD 1348.02 Million in 2017 and is expected to witness a CAGR of 4.27% over the forecast period. Increasing efforts are being witnessed toward the development of advanced products.
Increasing use of licorice extracts in food industry and growing demand for natural ingredient is projected to boost growth of the licorice market. Licorice extracts are further segmented on the basis of application, which includes food & beverages, pharmaceutical, tobacco, and others. Pharmaceutical segment is expected to account for the highest revenue share over the forecast period, due to increasing use of licorice extracts in medicines due to its anti-microbial properties.
We tend to believe this industry becomes more and more mature, and the consumption increasing rate will show a smooth curve.
Key players in global monoammonium glycyrrhizinate market include: Mafco Worldwide LLC, Alps Pharmaceutical Ind, ATP Glycyrrhizinate Center, Peter Whiting Chemicals, Tiansheng Pharmaceutical, Fujie Pharmaceutical, Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, Sabinsa Corporation, Gansu Yanlan Pharmaceutical